Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Br J Haematol. 2014 Nov; 167(3):394-401.
View in:
PubMed
subject areas
Adolescent
Adolescent
Antibodies, Monoclonal, Murine-Derived
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow
Bone Marrow
Burkitt Lymphoma
Burkitt Lymphoma
Central Nervous System Neoplasms
Central Nervous System Neoplasms
Child
Child
Consolidation Chemotherapy
Consolidation Chemotherapy
Cyclophosphamide
Cyclophosphamide
Cytarabine
Cytarabine
Disease-Free Survival
Disease-Free Survival
Doxorubicin
Doxorubicin
Drug Administration Schedule
Drug Administration Schedule
Etoposide
Etoposide
Female
Female
Genes, myc
Genes, myc
Humans
Humans
Immunotherapy
Immunotherapy
Infusions, Intravenous
Infusions, Intravenous
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Lymphoma, B-Cell
Lymphoma, B-Cell
Maintenance Chemotherapy
Maintenance Chemotherapy
Male
Male
Methotrexate
Methotrexate
Prednisone
Prednisone
Remission Induction
Remission Induction
Rituximab
Rituximab
Typhlitis
Typhlitis
Vincristine
Vincristine
authors with profiles
John Kimble Frazer